Close

Publications

vaccine-impact/epi_covid.
ABBAS, KM;
2020
, Github (2020).
Abuga, KM; JONES-WARNER, W; HAFALLA, JC R;
2020
Parasite Immunology, (2020).43 2 10.1111/pim.12795.
SAFETY AND IMMUNOGENICITY OF A 2-DOSE HETEROLOGOUS VACCINE AGAINST EBOLA IN AFRICAN CHILDREN AND ADOLESCENTS.
Afolabi, M; Mutua, G; ANYWAINE, Z; Kibuuka, H; ISHOLA, D; Leigh, B; Baiden, F; Owusu-Kyei, K; MANNO, D; Greenwoood, B; WATSON-JONES, D;
2020
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, (2020).101 5_Suppl
Increasing Access to Vaccine-Relevant Systematic Reviews: The SYSVAC database.
BURCHETT, H; FERNANDES, S; Jo, C; Harder, T; JIT, M; SCOTT, A;
2020
(2020).
Wu, L; Mwesigwa, J; Affara, M; Bah, M; Correa, S; Hall, T; Singh, SK; Beeson, JG; TETTEH, KK A; KLEINSCHMIDT, I; D'ALESSANDRO, U; DRAKELEY, C;
2020
BMC MEDICINE, (2020).18 1 10.1186/s12916-020-01724-5.
SANDMANN, FG; DAVIES, NG; VASSALL, A; EDMUNDS, WJ; JIT, M; Centre for the Mathematical Modelling of Infectiou,;
2020
medRxiv preprint, (2020).21 7 10.1016/S1473-3099(21)00079-7.
SANDMANN, F; JIT, M; Andrews, N; Buckley, HL; Campbell, H; Ribeiro, S; Sile, B; Stowe, J; Tessier, E; Ramsay, M; Choi, YH; Amirthalingam, G;
2020
CLINICAL INFECTIOUS DISEASES, (2020).71 8 10.1093/cid/ciaa165.